← Back to Clinical Trials
Recruiting NCT07676695

NCT07676695 Twin-Block and LIPUS for TMJ Outcomes in Skeletal Class II Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07676695
Status Recruiting
Phase
Sponsor Al-Azhar University
Condition CLASS II DIVISION 1 MALOCCLUSION
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2026-06-18
Primary Completion 2027-06-30

Eligibility & Interventions

Sex All sexes
Min Age 10 Months
Max Age 14 Months
Study Type INTERVENTIONAL
Interventions
ultrasound

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 24 participants in total. It began in 2026-06-18 with a primary completion date of 2027-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Evaluation of the efficacy of early treatment of skeletal class II patients with twin-block in conjunction with low intensity pulsed ultrasound on temporomandibular joint region: a prospective clinical trial

Eligibility Criteria

Inclusion Criteria: * Skeletal class II due to retrognathic mandible. * Angle's class II Molar relationship. * All patients involved in the study were in stages II and III based on the modified cervical vertebral maturation stages (CVMS) by Bacetti et al.5 * Proclined upper incisors * Increased overjet \> 5 mm. * Aligned lower arch or average inclination * Minimal crowding of lower arch. * No history of previous orthodontic treatment. Exclusion Criteria: * Skeletal class II due to prognathic maxilla. * Patient with gross facial asymmetry. * Previous orthodontic or orthopedic treatment. * Clinical signs and symptoms of any Temporomandibular joint disorders. * Increased anterior facial vertical dimension. * Poor oral hygiene.

Contact & Investigator

Central Contact

Mohamed Ha Hablas

✉ Mohamedhablas1995@gmail.com

📞 01278988226

Principal Investigator

Khaled Fa Abdallah

STUDY DIRECTOR

Alazhar university in cairo

Frequently Asked Questions

Who can join the NCT07676695 clinical trial?

This trial is open to participants of all sexes, aged 10 Months or older, up to 14 Months, studying CLASS II DIVISION 1 MALOCCLUSION. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07676695 currently recruiting?

Yes, NCT07676695 is actively recruiting participants. Contact the research team at Mohamedhablas1995@gmail.com for enrollment information.

Where is the NCT07676695 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07676695 clinical trial?

NCT07676695 is sponsored by Al-Azhar University. The principal investigator is Khaled Fa Abdallah at Alazhar university in cairo. The trial plans to enroll 24 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology